Ye Fang
Department of Hematology, Beijing Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China.
Oncotarget. 2017 Dec 20;9(4):5445-5458. doi: 10.18632/oncotarget.23539. eCollection 2018 Jan 12.
T-cell acute lymphoblastic leukemia (T-ALL) is a lymphoid malignancy caused by the oncogenic transformation of immature T-cell progenitors. Many biologically relevant genetic and epigenetic alterations have been identified as driving factors for this transformation. Recently, microRNAs (miRNAs) have been shown to influence various leukemias, including T-ALL. Aberrant expression of miRNAs can function as either oncogenes or tumor suppressors in T-ALL through the regulation of cell migration, invasion, proliferation, apoptosis, and chemoresistance. This occurs by targeting key signaling pathways or transcriptional factors that play a critical role in T-ALL pathology and progression. Different miRNA expression profiles have been linked to specific genetic subtypes of human T-ALL. Furthermore, miRNAs can also act as independent prognostic factors to predict clinical outcomes for T-ALL patients. In the current review, we will focus on the role of miRNAs in the development and progression of T-ALL.
T细胞急性淋巴细胞白血病(T-ALL)是一种由未成熟T细胞祖细胞发生致癌转化引起的淋巴恶性肿瘤。许多具有生物学相关性的基因和表观遗传改变已被确定为这种转化的驱动因素。最近,微小RNA(miRNA)已被证明会影响包括T-ALL在内的各种白血病。miRNA的异常表达可通过调节细胞迁移、侵袭、增殖、凋亡和化疗耐药性,在T-ALL中发挥癌基因或肿瘤抑制基因的作用。这是通过靶向在T-ALL病理和进展中起关键作用的关键信号通路或转录因子来实现的。不同的miRNA表达谱与人类T-ALL的特定基因亚型有关。此外,miRNA还可作为独立的预后因素来预测T-ALL患者的临床结局。在本综述中,我们将重点关注miRNA在T-ALL发生发展中的作用。